X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (76017) 76017
Newsletter (7842) 7842
Newspaper Article (5127) 5127
Publication (4377) 4377
Book Review (968) 968
Magazine Article (664) 664
Trade Publication Article (354) 354
Book Chapter (332) 332
Web Resource (83) 83
Book / eBook (82) 82
Conference Proceeding (81) 81
Transcript (64) 64
Dissertation (33) 33
Paper (12) 12
Data Set (10) 10
Reference (9) 9
Government Document (6) 6
Streaming Video (2) 2
Journal / eJournal (1) 1
Presentation (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58080) 58080
anticoagulants (42878) 42878
anticoagulants - therapeutic use (31488) 31488
female (28011) 28011
male (27323) 27323
index medicus (27158) 27158
middle aged (19152) 19152
aged (18585) 18585
adult (13684) 13684
anticoagulants - administration & dosage (12737) 12737
anticoagulants - adverse effects (12590) 12590
risk factors (12334) 12334
warfarin (11089) 11089
thrombosis (10466) 10466
stroke (10246) 10246
treatment outcome (10094) 10094
atrial fibrillation (9678) 9678
cardiac & cardiovascular systems (9221) 9221
hematology (9113) 9113
peripheral vascular disease (8588) 8588
research (8440) 8440
thromboembolism (8290) 8290
care and treatment (7410) 7410
aged, 80 and over (7344) 7344
surgery (7157) 7157
prevention (6710) 6710
drug therapy (6594) 6594
medicine, general & internal (6386) 6386
therapy (6127) 6127
warfarin - therapeutic use (5981) 5981
anticoagulation (5890) 5890
retrospective studies (5846) 5846
heparin (5754) 5754
risk (5586) 5586
heparin - therapeutic use (5251) 5251
analysis (5239) 5239
atrial fibrillation - drug therapy (5239) 5239
management (5146) 5146
administration, oral (5091) 5091
venous thromboembolism (4960) 4960
patients (4953) 4953
mortality (4934) 4934
time factors (4853) 4853
medical research (4842) 4842
animals (4798) 4798
hemorrhage - chemically induced (4674) 4674
health aspects (4442) 4442
pharmacology & pharmacy (4350) 4350
medicine, experimental (4275) 4275
aspirin (4116) 4116
abridged index medicus (4055) 4055
medicine & public health (4049) 4049
prospective studies (3995) 3995
stroke - prevention & control (3927) 3927
follow-up studies (3840) 3840
anticoagulants - pharmacology (3829) 3829
cardiac arrhythmia (3811) 3811
platelet aggregation inhibitors - therapeutic use (3808) 3808
atrial fibrillation - complications (3791) 3791
glycosaminoglycans (3765) 3765
molecular-weight heparin (3684) 3684
cardiology (3655) 3655
reports (3609) 3609
international normalized ratio (3595) 3595
warfarin - adverse effects (3580) 3580
hemorrhage (3555) 3555
adolescent (3503) 3503
warfarin - administration & dosage (3474) 3474
risk assessment (3436) 3436
thromboembolism - prevention & control (3337) 3337
pregnancy (3322) 3322
dabigatran (3289) 3289
fibrinolytic agents - therapeutic use (3288) 3288
thrombin (3041) 3041
diagnosis (3014) 3014
rivaroxaban (2966) 2966
atrial-fibrillation (2962) 2962
deep-vein thrombosis (2924) 2924
recurrence (2914) 2914
heparin - adverse effects (2903) 2903
venous thrombosis - drug therapy (2884) 2884
pulmonary embolism (2847) 2847
clinical trials (2792) 2792
dosage and administration (2780) 2780
stroke - etiology (2738) 2738
heparin - administration & dosage (2716) 2716
anticoagulant (2703) 2703
venous thrombosis (2702) 2702
clinical neurology (2698) 2698
bleeding (2680) 2680
complications (2674) 2674
drug therapy, combination (2657) 2657
blood coagulation - drug effects (2654) 2654
heparin, low-molecular-weight - therapeutic use (2639) 2639
prognosis (2619) 2619
internal medicine (2616) 2616
coagulation (2612) 2612
incidence (2574) 2574
blood clot (2545) 2545
usage (2514) 2514
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (37) 37
Online Resources - Online (28) 28
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - May be requested in 6-10 wks (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (81489) 81489
German (2860) 2860
French (1481) 1481
Russian (932) 932
Japanese (765) 765
Spanish (746) 746
Italian (350) 350
Polish (248) 248
Chinese (231) 231
Portuguese (153) 153
Hungarian (151) 151
Swedish (137) 137
Danish (135) 135
Czech (115) 115
Dutch (107) 107
Norwegian (105) 105
Finnish (73) 73
Turkish (66) 66
Hebrew (62) 62
Korean (56) 56
Bulgarian (40) 40
Croatian (38) 38
Serbian (34) 34
Ukrainian (30) 30
Romanian (25) 25
Slovak (15) 15
Lithuanian (12) 12
Icelandic (7) 7
Bosnian (5) 5
Arabic (3) 3
Slovenian (3) 3
Greek (2) 2
Estonian (1) 1
Georgian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e44S - e88S
Background: The objective of this article is to summarize the published literature concerning the pharmacokinetics and pharmacodynamics of oral anticoagulant... 
GAMMA-CARBOXYGLUTAMIC ACID | INTRAVENOUS PHYTONADIONE VITAMIN-K-1 | FACTOR-XA INHIBITOR | VENOUS LIMB GANGRENE | EUROPEAN CONCERTED ACTION | LOW-INTENSITY WARFARIN | RESPIRATORY SYSTEM | VITAMIN-K ANTAGONISTS | TOTAL HIP-REPLACEMENT | INTERNATIONAL NORMALIZED RATIO | NONVALVULAR ATRIAL-FIBRILLATION | CRITICAL CARE MEDICINE | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | United States | Humans | Pyridines - pharmacokinetics | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Antithrombins - pharmacokinetics | Dose-Response Relationship, Drug | Rivaroxaban | Pyridines - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Benzimidazoles - administration & dosage | Thrombosis - blood | Thrombosis - prevention & control | Benzimidazoles - adverse effects | Morpholines - adverse effects | Pyridines - administration & dosage | Administration, Oral | Morpholines - administration & dosage | Benzimidazoles - pharmacokinetics | Anticoagulants - adverse effects | Evidence-Based Medicine | Factor Xa - metabolism | Thiophenes - pharmacokinetics | Vitamin K - blood | Antithrombins - adverse effects | Anticoagulants - pharmacokinetics | Thrombosis - drug therapy | Morpholines - pharmacokinetics | Practice Guidelines as Topic | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e326S - e350S
Background: This guideline addresses the management of patients who are receiving anticoagulant or antiplatelet therapy and require an elective surgery or... 
VITAMIN-K-ANTAGONISTS | PERCUTANEOUS CORONARY INTERVENTION | PROSTHETIC HEART-VALVES | LOW-DOSE ASPIRIN | RESPIRATORY SYSTEM | MOLECULAR-WEIGHT HEPARIN | ORAL ANTICOAGULANT-THERAPY | TRANEXAMIC ACID MOUTHWASH | NONVALVULAR ATRIAL-FIBRILLATION | INTERNATIONAL NORMALIZED RATIO | DRUG-ELUTING STENTS | CRITICAL CARE MEDICINE | Perioperative Care | United States | Humans | Postoperative Complications - blood | Postoperative Complications - prevention & control | Aspirin - pharmacokinetics | Angioplasty, Balloon, Coronary | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Fibrinolytic Agents - pharmacokinetics | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - pharmacokinetics | Postoperative Complications - drug therapy | Thrombosis - blood | Thrombosis - prevention & control | Stents | Platelet Aggregation Inhibitors - adverse effects | Drug Administration Schedule | Atrial Fibrillation - drug therapy | Heart Valve Prosthesis | Risk Factors | Atrial Fibrillation - complications | Evidence-Based Medicine | Atrial Fibrillation - blood | Fibrinolytic Agents - administration & dosage | Thrombosis - drug therapy | Elective Surgical Procedures | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 02/2013, Volume 127, Issue 5, pp. 634 - 640
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e419S - e496S
Background: This article addresses the treatment of VTE disease. Methods: We generated strong (Grade 1) and weak (Grade 2) recommendations based on... 
RIGHT-VENTRICULAR DYSFUNCTION | RECURRENT VENOUS THROMBOEMBOLISM | TISSUE-PLASMINOGEN-ACTIVATOR | RESPIRATORY SYSTEM | ACUTE PULMONARY-EMBOLISM | MOLECULAR-WEIGHT HEPARIN | VENA-CAVA FILTER | ORAL ANTICOAGULANT-THERAPY | INTRAVENOUS UNFRACTIONATED HEPARIN | LONG-TERM TREATMENT | DEEP-VEIN-THROMBOSIS | CRITICAL CARE MEDICINE | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Venous Thrombosis - blood | Heparin, Low-Molecular-Weight - adverse effects | Hemorrhage - prevention & control | Long-Term Care | Heparin, Low-Molecular-Weight - therapeutic use | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Fibrinolytic Agents - therapeutic use | Venous Thrombosis - prevention & control | Polysaccharides - therapeutic use | Drug Administration Schedule | Venous Thrombosis - drug therapy | Administration, Oral | Risk Factors | Polysaccharides - adverse effects | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Pulmonary Embolism - blood | International Normalized Ratio | Diagnostic Imaging | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e1S - e23S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e531S - e575S
Background: The risk of stroke varies considerably across different groups of patients with atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is... 
DIRECT-CURRENT CARDIOVERSION | STROKE PREVENTION | RESPIRATORY SYSTEM | CLOPIDOGREL PLUS ASPIRIN | ORAL ANTICOAGULANT-THERAPY | RISK STRATIFICATION SCHEMES | MAJOR VASCULAR EVENTS | PULMONARY-VEIN ABLATION | ACUTE CORONARY SYNDROME | ECHOCARDIOGRAPHY-GUIDED CARDIOVERSION | ANTIARRHYTHMIC-DRUG THERAPY | CRITICAL CARE MEDICINE | Ticlopidine - therapeutic use | Humans | Electric Countershock | Hemorrhage - prevention & control | Dabigatran | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ticlopidine - adverse effects | Aspirin - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Benzimidazoles - therapeutic use | Stroke - prevention & control | beta-Alanine - adverse effects | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Ticlopidine - analogs & derivatives | Atrial Fibrillation - blood | International Normalized Ratio | Stroke - blood | Atrial Flutter - complications | Atrial Flutter - drug therapy | Hemorrhage - chemically induced | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
American Heart Journal, ISSN 0002-8703, 12/2016, Volume 182, pp. 1 - 8
Dual antiplatelet therapy (DAPT) is a fundamental treatment that optimizes clinical outcomes after percutaneous coronary intervention, especially in patients... 
DEFINITIONS | CARDIAC & CARDIOVASCULAR SYSTEMS | CLOPIDOGREL | METAANALYSIS | MYOCARDIAL-INFARCTION | EFFICACY | IMPLANTATION | BARE-METAL STENTS | DRUG-ELUTING STENTS | CLINICAL-OUTCOMES | Humans | Immunosuppressive Agents - therapeutic use | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Adult | Everolimus - therapeutic use | Female | Republic of Korea | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Treatment Outcome | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Hemorrhage - chemically induced | Drug Monitoring | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Medicine, Experimental | Medical research | Care and treatment | Coronary heart disease | Cardiac patients | Blood transfusions | Anticoagulants | Thoracic surgery | Life expectancy | Heart attacks | Enrollments | Comorbidity | Mortality | Cardiovascular disease | Angina pectoris | Clinical outcomes | Studies | Contrast agents | Hypotheses | Surgery | Coronary vessels | Acute coronary syndromes | Health risk assessment | Cardiology
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e737S - e801S
Background: Neonates and children differ from adults in physiology, pharmacologic responses to drugs, epidemiology, and long-term consequences of thrombosis.... 
INFERIOR VENA-CAVA | TISSUE-PLASMINOGEN-ACTIVATOR | ARTERIAL ISCHEMIC-STROKE | RESPIRATORY SYSTEM | CEREBRAL SINOVENOUS THROMBOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | HEPARIN-INDUCED THROMBOCYTOPENIA | SICKLE-CELL-DISEASE | HOMOZYGOUS PROTEIN-C | CRITICAL CARE MEDICINE | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | Upper Extremity Deep Vein Thrombosis - blood | Child, Preschool | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Upper Extremity Deep Vein Thrombosis - prevention & control | Hemorrhage - prevention & control | Secondary Prevention | Heparin - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Cardiac Catheterization | Vitamin K - antagonists & inhibitors | Societies, Medical | Platelet Aggregation Inhibitors - administration & dosage | Renal Veins | Thrombosis - blood | Thrombosis - prevention & control | Child | Infant, Newborn | Platelet Aggregation Inhibitors - adverse effects | Upper Extremity Deep Vein Thrombosis - drug therapy | Drug Administration Schedule | Risk Factors | Cooperative Behavior | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Interdisciplinary Communication | Thrombosis - etiology | Blood Coagulation Tests | Fibrinolytic Agents - administration & dosage | Thrombosis - drug therapy | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Intensive care medicine, ISSN 0342-4642, 2007, Volume 33, Issue 9, pp. 1563 - 1570
Journal Article
1959, Modern medical monographs, 20, 131
Book
American Heart Journal, ISSN 0002-8703, 2011, Volume 161, Issue 5, pp. 815 - 821.e6
Journal Article
1990, ISBN 0702014745, Volume 3/no. 3., x, p. 483-836.
Book